AstraZeneca’s (AZN) new drug lenisurad is an innovative selective uric acid reabsorption inhibitor (or SURI) therapy for the treatment of gout. According to Ardea Biosciences, a member of AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback